BAJAJ BROKING

Notification
No new Notification messages
Wagons Learning IPO is Open!
Apply for the Wagons Learning IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

524572

PHARMAID

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

PHARMAIDS PHARMACEUTICALS LTD. Share Price Update

As of the latest trading session, PHARMAIDS PHARMACEUTICALS LTD. share price is currently at ₹ 65.19, which is up by ₹ 0.19 from its previous closing. Today, the stock has fluctuated between ₹ 64.15 and ₹ 65.99. Over the past year, PHARMAIDS PHARMACEUTICALS LTD. has achieved a return of 13.83 %. In the last month alone, the return has been -7.04 %. Read More...

PHARMAIDS PHARMACEUTICALS LTD. fundamentals


  • Market cap (Cr)

  • P/E Ratio (TTM)

  • Beta

  • Book Value / share

  • Return on equity

    %

  • EPS (TTM)

  • Dividend yield

    %

  • Net profit/quarter (Cr)

info icon alternate text
  • Market cap (Cr)

    229.91

  • P/E Ratio (TTM)

    -35.25

  • Beta

    -0.10

  • Book Value / share

    19.40

  • Return on equity

    0.00%

  • EPS (TTM)

    0.00

  • Dividend yield

    %

  • Net profit/quarter (Cr)

    -1.59

info icon alternate text

PHARMAIDS PHARMACEUTICALS LTD. Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2024 (Values in Cr)
Revenue 1.21
Operating Expense 3.06
Net Profit -1.59
Net Profit Margin (%) -131.40
Earnings Per Share (EPS) -0.45
EBITDA -1.73
Effective Tax Rate (%) 13.51
Particulars SEP 2024 (Values in Cr)
Revenue 0.83
Operating Expense 2.01
Net Profit -1.01
Net Profit Margin (%) -121.68
Earnings Per Share (EPS) -0.29
EBITDA -1.13
Effective Tax Rate (%) 15.12
Particulars JUN 2024 (Values in Cr)
Revenue 0.17
Operating Expense 1.94
Net Profit -1.62
Net Profit Margin (%) -952.94
Earnings Per Share (EPS) -0.46
EBITDA -1.71
Effective Tax Rate (%) 8.47
Particulars MAR 2024 (Values in Cr)
Revenue 0.01
Operating Expense 2.15
Net Profit -2.24
Net Profit Margin (%) -22400.00
Earnings Per Share (EPS) -0.98
EBITDA -1.76
Effective Tax Rate (%) -6.16
Particulars DEC 2023 (Values in Cr)
Revenue 0.02
Operating Expense 2.52
Net Profit -1.15
Net Profit Margin (%) -5749.99
Earnings Per Share (EPS) -0.54
EBITDA -1.67
Effective Tax Rate (%) 33.52
Particulars MAR 2024 (Values in Cr)
Revenue 0.03
Operating Expense 6.91
Net Profit -4.95
Net Profit Margin (%) -16500.00
Earnings Per Share (EPS) -2.18
EBITDA -5.58
Effective Tax Rate (%) 18.71
Particulars MAR 2023 (Values in Cr)
Revenue 0.00
Operating Expense 9.91
Net Profit -7.56
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -5.86
EBITDA -9.89
Effective Tax Rate (%) 23.71
Particulars MAR 2022 (Values in Cr)
Revenue 3.94
Operating Expense 3.81
Net Profit 0.15
Net Profit Margin (%) 3.80
Earnings Per Share (EPS) 0.14
EBITDA 0.15
Effective Tax Rate (%) 0.00
Particulars MAR 2021 (Values in Cr)
Revenue 8.55
Operating Expense 8.49
Net Profit 0.09
Net Profit Margin (%) 1.05
Earnings Per Share (EPS) 0.09
EBITDA 0.13
Effective Tax Rate (%) 0.00
Particulars MAR 2020 (Values in Cr)
Revenue 0.00
Operating Expense 0.37
Net Profit 0.03
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.03
EBITDA -0.34
Effective Tax Rate (%) 107.89
Particulars MAR 2024 (Values in Cr)
Book Value / Share 20.15
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.14
EBITDA Margin -18600.00
Particulars MAR 2023 (Values in Cr)
Book Value / Share 10.46
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2022 (Values in Cr)
Book Value / Share 8.44
ROE % 1.36
ROCE % 1.36
Total Debt to Total Equity 0.00
EBITDA Margin 3.81
Particulars MAR 2021 (Values in Cr)
Book Value / Share 8.30
ROE % 0.82
ROCE % 0.82
Total Debt to Total Equity 0.00
EBITDA Margin 1.52
Particulars MAR 2020 (Values in Cr)
Book Value / Share 8.21
ROE % 0.31
ROCE % -3.92
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 4.80
Total Assets 91.34
Total Liabilities 91.34
Total Equity 70.49
Share Outstanding 35267812
Price to Book Ratio 2.58
Return on Assets (%) -8.72
Return on Capital (%) -10.51
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 12.75
Total Assets 24.58
Total Liabilities 24.58
Total Equity 22.46
Share Outstanding 214862340
Price to Book Ratio 2.09
Return on Assets (%) -30.73
Return on Capital (%) -33.64
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.40
Total Assets 11.11
Total Liabilities 11.11
Total Equity 8.67
Share Outstanding 21486234
Price to Book Ratio 1.48
Return on Assets (%) 1.30
Return on Capital (%) 1.67
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 2.45
Total Assets 85.00
Total Liabilities 85.00
Total Equity 71.06
Share Outstanding 35267812
Price to Book Ratio 2.58
Return on Assets (%) -5.82
Return on Capital (%) -5.92
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 12.75
Total Assets 24.54
Total Liabilities 24.54
Total Equity 22.42
Share Outstanding 21486234
Price to Book Ratio 2.09
Return on Assets (%) -30.77
Return on Capital (%) -33.69
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.40
Total Assets 11.11
Total Liabilities 11.11
Total Equity 8.67
Share Outstanding 10268819
Price to Book Ratio 1.48
Return on Assets (%) 1.30
Return on Capital (%) 1.67
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.20
Total Assets 9.11
Total Liabilities 9.11
Total Equity 8.52
Share Outstanding 10268819
Price to Book Ratio 1.35
Return on Assets (%) 1.02
Return on Capital (%) 1.09
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.02
Total Assets 8.45
Total Liabilities 8.45
Total Equity 8.43
Share Outstanding 10268819
Price to Book Ratio 0.55
Return on Assets (%) 0.39
Return on Capital (%) 0.4
Particulars MAR 2024 (Values in Cr)
Net Income -15.62
Cash from Operations -10.61
Cash from Investing -74.99
Cash from Financing 77.65
Net change in Cash -7.95
Free Cash Flow 12.24
Particulars MAR 2023 (Values in Cr)
Net Income -9.90
Cash from Operations -4.01
Cash from Investing -4.94
Cash from Financing 21.30
Net change in Cash 12.34
Free Cash Flow -2.34
Particulars MAR 2022 (Values in Cr)
Net Income 0.14
Cash from Operations -0.25
Cash from Investing 0.46
Cash from Financing 0.00
Net change in Cash 0.20
Free Cash Flow -0.25
Particulars MAR 2024 (Values in Cr)
Net Income -6.08
Cash from Operations -3.44
Cash from Investing -72.50
Cash from Financing 65.66
Net change in Cash -10.29
Free Cash Flow 12.92
Particulars MAR 2023 (Values in Cr)
Net Income -9.90
Cash from Operations -4.01
Cash from Investing -4.94
Cash from Financing 21.31
Net change in Cash 12.35
Free Cash Flow -2.34
Particulars MAR 2022 (Values in Cr)
Net Income 0.14
Cash from Operations -0.25
Cash from Investing 0.46
Cash from Financing 0.00
Net change in Cash 0.20
Free Cash Flow -0.25
Particulars MAR 2021 (Values in Cr)
Net Income 0.08
Cash from Operations 0.40
Cash from Investing -0.22
Cash from Financing 0.00
Net change in Cash 0.17
Free Cash Flow 0.40
Particulars MAR 2020 (Values in Cr)
Net Income -0.37
Cash from Operations -0.75
Cash from Investing 0.66
Cash from Financing 0.00
Net change in Cash -0.08
Free Cash Flow -0.70
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 36.46 19.60 1.99 279.41 34.11 / 77.70
BLISS GVS PHARMA LTD 119.00 15.60 1.24 1253.91 92.25 / 184.95
CIPLA LTD 1549.65 25.08 4.41 125155.99 1310.05 / 1702.00
FERMENTA BIOTECH LIMITED 260.70 21.60 2.64 767.27 145.00 / 449.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 36.46 21.96 6.19 279.41 34.11 / 77.70
AMRUTAJAN HEALTH LTD 692.80 40.61 6.72 2002.93 548.05 / 861.40
ASTRAZENECA PHARMA IND LT 8665.50 129.24 31.88 21663.75 5000.00 / 9199.00
BLISS GVS PHARMA LTD 119.00 15.45 1.22 1253.91 92.25 / 184.95

PHARMAIDS PHARMACEUTICALS LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
64.51 -0.75 redarrow
red-green-graph indicator
14 Bearish
2 Bullish
  • 5 Days 65.00
  • 26 Days 66.60
  • 10 Days 65.40
  • 50 Days 67.30
  • 12 Days 65.60
  • 100 Days 66.00
  • 20 Days 66.20
  • 200 Days 61.50
65.50 PIVOT

First Support

63.50

First Resistance

66.99

Second Support

62.01

Second Resistance

68.99

Third Support

60.01

Third Resistance

70.48

RSI

42.03

ADX

26.48

MACD

-0.97

Williams % R

-72.79

Commodity Channel Index (CCI)

-94.10

Date

2025-04-30

Week

5915.00

Same Day

7689.00

Month

5205.00

1 Year

-0.10

3 Year

0.17

Over 1 Month

-7.04%

down

Over 1 Year

13.83%

down

Over 3 Months

-5.59%

down

Over 3 Years

71.22%

down

Over 6 Months

57.72%

down

Over 5 Years

67.31%

down

Invest with Confidence

Left Arrow
MTF boost
Buy Now. Pay Later

Boost your capital upto 5 X

img
IPO boost
Invest in IPOs
They give good returns
img
Right Arrow

PHARMAIDS PHARMACEUTICALS LTD. shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
94.78%
Promoter Holdings
5.21%
FII
0.0%
DII
0.0%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Shankarappa Nagaraja Vinaya Babu 7020854.0 (19.91%) Public Shareholding
Shreedhara Shetty 6010621.0 (17.04%) Public Shareholding
Gokaram Ramkrishna Balaji 3195815.0 (9.06%) Public Shareholding
Tumkur Trade Center Pvt Ltd 1568000.0 (4.45%) Public Shareholding
Sadhanala Venkata Rao 1550526.0 (4.4%) Shareholding of Promoter and Promoter Group
Venu Madhava Kaparthy 867281.0 (2.46%) Public Shareholding
Makam Sreevalli 780242.0 (2.21%) Public Shareholding
Balagangadhara B C 650000.0 (1.84%) Public Shareholding
Mini Manikantan 500000.0 (1.42%) Public Shareholding
Venkatesh Mahendra 438097.0 (1.24%) Public Shareholding
S Prasad 425201.0 (1.21%) Public Shareholding
Padmaja Kalyani Sadhanala 189146.0 (0.54%) Shareholding of Promoter and Promoter Group
Pilli Meena Kumari 56000.0 (0.16%) Shareholding of Promoter and Promoter Group
Viswa Prasad Sadhanala 19153.0 (0.05%) Shareholding of Promoter and Promoter Group
Surekha Prashant Dave 9159.0 (0.03%) Shareholding of Promoter and Promoter Group
Kant Rao 7300.0 (0.02%) Shareholding of Promoter and Promoter Group
B. Venkatswamy 6070.0 (0.02%) Shareholding of Promoter and Promoter Group
Uttam P Jain 1000.0 (0.0%) Shareholding of Promoter and Promoter Group
Sureshkumar 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Baghi Rao Pankaj Sadhanala 25.0 (0.0%) Shareholding of Promoter and Promoter Group
Maharani Maheshwari Sadhanala 25.0 (0.0%) Shareholding of Promoter and Promoter Group
Dadi Urmila 25.0 (0.0%) Shareholding of Promoter and Promoter Group
Sadhanalla Dara Kalyani 1000.0 (0.0%) Shareholding of Promoter and Promoter Group
Rangoori Kantham 1000.0 (0.0%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

PHARMAIDS PHARMACEUTICALS LTD. corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

PHARMAIDS PHARMACEUTICALS LTD. Share Price

Pharmaids Pharmaceuticals Limited, incorporated in March, 1989 at Hyderabad, Telangana are the suppliers of Quality Grade range of speciality chemicals, skin care, hospital care and generic products in the areas of Orthopedic, Neuro and Gastro etc. The technical team uses quality proven chemical compounds and standard processing methods maintaining proper hygiene standards. The Company is primarily engaged in business of manufacturing of Generics, Bulk Drugs in various forms like tablets, capsules, liquids and powders etc., in allopathic and herbal Ayurvedic and Natural drug formulation.

Emergent Bio Naturals Limited (EBNL) was amalgamated with the Company in 2019-20 and the Scheme of Amalgamation was effective on September 27, 2019. Pursuant to the Scheme, 69,05,734 Equity Shares were allotted to Shareholders of Emergent Bio Naturals Limited on November 27, 2019.

The Company acquired 25.5% stake as 1st tranche in Anugraha Chemicals, a Partnership Firm, registered under Karnataka Partnership Rules, 1954 on February 1, 2023.

Parent organization Indian Private
NSE symbol [-]
Founded 1989
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Share Price of Pharmaids Pharmaceuticals Ltd?

Answer Field

The share price of Pharmaids Pharmaceuticals Ltd for NSE is ₹ 0.00 and for BSE is ₹ 64.51.

What is the Market Cap of Pharmaids Pharmaceuticals Ltd?

Answer Field

The market cap of Pharmaids Pharmaceuticals Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 2,27.50 Cr. as of now.

What is the 52 Week High and Low of Pharmaids Pharmaceuticals Ltd?

Answer Field

The 52 Week High and Low of Pharmaids Pharmaceuticals Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 87.46 and ₹ 31.90.

How to Buy Pharmaids Pharmaceuticals Ltd share?

Answer Field

You can trade in Pharmaids Pharmaceuticals Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Pharmaids Pharmaceuticals Ltd?

Answer Field

The 1 year returns on the stock has been 0.0%.

What is the Current Share Price of Pharmaids Pharmaceuticals Ltd?

Answer Field

Pharmaids Pharmaceuticals Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 64.51 as on Apr 30 2025 03:25 PM.

What is the Market Cap of Pharmaids Pharmaceuticals Ltd Share?

Answer Field

The market cap of Pharmaids Pharmaceuticals Ltd for NSE ₹ 0.0 & for BSE ₹ 2,27.50 as on Apr 30 2025 03:25 PM.

What is the P/E Ratio of Pharmaids Pharmaceuticals Ltd Share?

Answer Field

As on Apr 30 2025 03:25 PM the price-to-earnings (PE) ratio for Pharmaids Pharmaceuticals Ltd share is -35.25.

What is the PB ratio of Pharmaids Pharmaceuticals Ltd Share?

Answer Field

As on Apr 30 2025 03:25 PM, the price-to-book (PB) ratio for Pharmaids Pharmaceuticals Ltd share is 19.40.

How to Buy Pharmaids Pharmaceuticals Ltd Share?

Answer Field

You can trade in Pharmaids Pharmaceuticals Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Pharmaids Pharmaceuticals Ltd Share on Bajaj Broking App?

Answer Field

To buy Pharmaids Pharmaceuticals Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Pharmaids Pharmaceuticals Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|